Titan Medical (NASDAQ:TMDI) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings.
This table compares Titan Medical and Inspire Medical Systems’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Inspire Medical Systems||-61.07%||-32.23%||-26.42%|
This table compares Titan Medical and Inspire Medical Systems’ top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Titan Medical||N/A||N/A||-$41.91 million||N/A||N/A|
|Inspire Medical Systems||$82.05 million||77.28||-$33.24 million||($1.40)||-166.71|
Inspire Medical Systems has higher revenue and earnings than Titan Medical.
Institutional & Insider Ownership
3.3% of Titan Medical shares are held by institutional investors. Comparatively, 96.3% of Inspire Medical Systems shares are held by institutional investors. 6.6% of Inspire Medical Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
This is a summary of current ratings and recommmendations for Titan Medical and Inspire Medical Systems, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Inspire Medical Systems||0||3||7||0||2.70|
Titan Medical presently has a consensus target price of $4.00, suggesting a potential upside of 145.40%. Inspire Medical Systems has a consensus target price of $168.55, suggesting a potential downside of 27.79%. Given Titan Medical’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Titan Medical is more favorable than Inspire Medical Systems.
Risk & Volatility
Titan Medical has a beta of 3.53, suggesting that its share price is 253% more volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 1.71, suggesting that its share price is 71% more volatile than the S&P 500.
About Titan Medical
Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the SPORT Surgical System, a single-port robotic surgical system that comprises a surgeon-controlled patient cart, which includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The SPORT Surgical System enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and abdominal indications. Titan Medical Inc. is headquartered in Toronto, Canada.
About Inspire Medical Systems
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Receive News & Ratings for Titan Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Medical and related companies with MarketBeat.com's FREE daily email newsletter.